UV-Spectrophotometry – Multicomponent Mode of Analysis for Simultaneous Estimation of Brinzolamide and Brimonidine Tartrate in Bulk and Ophthalmic Formulation

dc.contributor.authorVikram L. Jadhav
dc.contributor.authorAmod S. Patil
dc.contributor.authorSuraj R. Chaudhari
dc.contributor.authorAtul A. Shirkhedkar
dc.date.accessioned2025-12-18T05:54:23Z
dc.date.available2025-12-18T05:54:23Z
dc.date.issued2019-05-10
dc.description.abstractBrinzolamide (BRZ) and Brimonidine Tartrate (BT) in combination are available as an ophthalmic suspension in the ratio of 5:1. A simple, reproducible and efficient method for the simultaneous determination of BRZ and BT in Bulk and Ophthalmic formulation has been developed. The absorbance was assessed at two wavelengths i.e. 252.40 nm (λ max of BRZ) and 246 nm (λmax of BT) in methanol. In this method, BRZ and BT executed linearity in the concentration range of 5-35 μg/mL and 3-18 μg/mL, respectively at their respective λ max. The developed method was found to be accurate, precise and rugged as marked by small values of % RSD according to ICH guidelines.
dc.identifier.issn2321-2217
dc.identifier.issn2321-2225
dc.identifier.otherhttps://doi.org/10.15415/jptrm.2019.71005
dc.identifier.urihttps://demodspace.chitkara.edu.in/handle/123456789/231
dc.language.isoen
dc.publisherChitkara University Publications
dc.subjectBrinzolamide
dc.subjectBrimonidine tartrate
dc.subjectUV-Spectrophotometry
dc.subjectMulticomponent mode of analysis
dc.subjectValidation
dc.titleUV-Spectrophotometry – Multicomponent Mode of Analysis for Simultaneous Estimation of Brinzolamide and Brimonidine Tartrate in Bulk and Ophthalmic Formulation
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
JPTRM Volume 7 Issue 1 005.pdf
Size:
326.55 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: